GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,016 | +33.3% | 183,862 | 0.0% | 0.01% | +50.0% |
| Q2 2023 | $264,762 | -31.4% | 183,862 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $386,111 | +1279.0% | 183,862 | +959.4% | 0.01% | +600.0% |
| Q3 2022 | $28,000 | +21.7% | 17,355 | 0.0% | 0.00% | – |
| Q2 2022 | $23,000 | -17.9% | 17,355 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $28,000 | -3.4% | 17,355 | +25.3% | 0.00% | 0.0% |
| Q4 2021 | $29,000 | -46.3% | 13,855 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $54,000 | +22.7% | 13,855 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $44,000 | +46.7% | 13,855 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | -3.2% | 13,855 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $31,000 | -16.2% | 13,855 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $37,000 | -11.9% | 13,855 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $42,000 | +55.6% | 13,855 | 0.0% | 0.00% | +200.0% |
| Q1 2020 | $27,000 | -32.5% | 13,855 | 0.0% | 0.00% | -66.7% |
| Q4 2019 | $40,000 | -21.6% | 13,855 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $51,000 | – | 13,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |